<DOC>
	<DOC>NCT01456000</DOC>
	<brief_summary>The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrillation by creating electrical isolation of the pulmonary veins.</brief_summary>
	<brief_title>HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)</brief_title>
	<detailed_description>A randomized, controlled trial designed to demonstrate the safety and effectiveness of the experimental device to deliver pulmonary vein isolation as a treatment for symptomatic atrial fibrillation.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>18 to 75 years. paroxysmal atrial fibrillation failure of at least one AAD others overall good health as established by multiple criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>AF</keyword>
	<keyword>PAF</keyword>
	<keyword>PVI</keyword>
	<keyword>ablation</keyword>
	<keyword>paroxysmal atrial fibrillation</keyword>
	<keyword>pulmonary vein isolation</keyword>
</DOC>